Fagerholm, V <br/><br/>
alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.  [electronic resource] 

 -  British journal of pharmacology  Jul 2008 
 - 1287-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/bjp.2008.186  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Antagonists<br/>Adrenergic alpha-Antagonists--pharmacology<br/>Adrenergic beta-Antagonists--pharmacology<br/>Animals<br/>Atropine Derivatives--pharmacology<br/>Benzofurans--pharmacology<br/>Blood Glucose--metabolism<br/>Drug Synergism<br/>Fasting--physiology<br/>Glyburide--pharmacology<br/>Hypoglycemic Agents--pharmacology<br/>Imidazoles--pharmacology<br/>Insulin--blood<br/>Insulin Secretion<br/>Isoquinolines--pharmacology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Muscarinic Antagonists--pharmacology<br/>Naphthyridines--pharmacology<br/>Phentolamine--pharmacology<br/>Propranolol--pharmacology<br/>Receptors, Adrenergic, alpha-2--genetics